[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100608638":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":11,"centralContacts":11,"locations":11,"responsibleParty":20,"collaborators":22,"id":25,"slug":26,"hasResults":27,"nctId":28,"briefTitle":29,"officialTitle":30,"acronym":11,"eligibilityCriteria":31,"healthyVolunteers":27,"sex":32,"minAge":33,"maxAge":11,"enrollmentInfo":34,"targetDuration":11,"studyType":37,"phases":38,"briefSummary":40,"conditions":41,"keywords":11,"overallStatus":43,"whyStopped":11,"lastUpdateSubmitDate":44,"lastUpdatePostDateStruct":45,"startDateStruct":48,"completionDateStruct":50,"leadSponsor":52,"locationsCount":11},{"fullName":5,"class":6},"YSLab","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"subject using the device","EXPERIMENTAL",null,[13],"Device: Spray pompe nasal confort",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":11},"DEVICE","Spray pompe nasal confort","Seawater solution with hyaluronan",[9],{"type":21,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR",[23],{"name":24,"class":6},"Eclevar Medtech","100608638","evaluation-of-a-medical-device-based-on-isotonic-seawater-and-hyaluronic-acid-used-as-a-nasal-spray-100608638",false,"NCT07204158","Evaluation of a Medical Device Based on Isotonic Seawater and Hyaluronic Acid Used as a Nasal Spray","Clinical Performance Evaluation of a Medical Device Based on Isotonic Seawater and Hyaluronic Acid Used as a Nasal Spray in Children and Adults With Nasal Dryness: a Prospective, Multicentric, Non-randomized Study in Real-life Conditions.","Inclusion Criteria:\n\n* IC1. Male, female over 6 years old.\n* IC2 Rhinoscopy score of at least 6, with a dryness symptom score of at least 2.\n* IC3. Have a smartphone that can use MILO application, for any patient that wishes to answer the questionnaires on their phone.\n* IC4. Patient and\u002For parent\u002Flegal guardian can understand and comply with protocol requirements and instructions.\n* IC5. Patient willing to not change their daily habits including but not limited to Smoking, use of fireplace candles, air conditioning, cold air, medication and dehumidifier.\n* IC6. Signed informed consent (by patient and\u002For parent\u002Flegal guardian).\n\nExclusion Criteria:\n\n* EC1. Patients taking anticoagulants, over-the-counter or prescription systemic\u002Ftopical corticosteroids, antibiotics, antihistamines, non-steroidal anti-inflammatory drugs (NSAIDs), leukotriene antagonists, topical or systemic decongestants or any treatment for relieve of nasal symptoms (except acetaminophen) in the two weeks prior to Visit 1 and during the study;\n* EC2. Patient with known hyper sensibility to the study treatment;\n* EC3. Patients using other nasal sprays, nasal pumps, nasal irrigation\u002Fwashing devices or nasal oils, creams or gels in the two weeks prior to Visit 1 and during the study;\n* EC4. Patients with any dermatological, respiratory or medical condition (e.g., asthma, pneumonia, laryngotracheobronchitis, sinusitis, nasal polyposis and chronic sinusitis, urticaria or eczema) that, in the opinion of the principal investigator, could interfere with the interpretation of study results;\n* EC5. Patients with a positive medical history of any significant illness in the 2 weeks preceding the study, which, in the opinion of the principal investigator, could interfere with the interpretation of study results;\n* EC6. Patients with nasal anatomical anomalies, e.g., severely deviated septum, congenital cleft lip\u002Fpalate, nasal hemorrhagic diathesis (assessed by principal investigator);\n* EC7. Patient that uses cocaine or other inhaled drugs\n* EC8. Patients with any clinically significant co-morbid condition that, in the opinion of the principal investigator, could interfere with the interpretation of study results;\n* EC9. Enrolled in another clinical trial or being in a period of exclusion from a previous clinical trial;\n* EC10. Women of childbearing age (except menopausal, hysterectomized, and sterilized) are not using effective contraception (oral contraceptives, intra-uterine devices, contraceptive implants, or condoms);\n* EC11. A person belonging to a population referred to in articles 64 (incapacitated subjects), 66 (pregnant or breastfeeding women), 67 (persons performing mandatory military service, persons deprived of liberty, persons who, due to a judicial decision) and 68 (patients in an emergency) of the MDR 2017\u002F745.","ALL","6 Years",{"count":35,"type":36},65,"ESTIMATED","INTERVENTIONAL",[39],"NA","The purpose of this study is to see whether the nasal spray can help improve hydration of the nasal mucosa, reduce discomfort linked to nasal dryness, and confirm its safety in patients suffering from nasal dryness.",[42],"Nasal Dryness","NOT_YET_RECRUITING","2025-10-02",{"date":46,"type":47},"2025-10-08","ACTUAL",{"date":49,"type":36},"2025-10-07",{"date":51,"type":36},"2026-02-28",{"name":5,"class":6}]